Elevated levels of METTL1 correlates with poor prognosis of various cancers, including bladder cancer (BLCA) (18, 19), hepatocellular carcinoma (HCC) (15, 20), lung cancer (8), colon cancer (21), liver cancer (22), and glioma (23). The gene discussed is METTL1; the disease is cancer.